KOPRAN.NS Tiesioginiai signalai | Didinkite pelną su Getagraph.com

Live Chart Being Loaded With Signals

Commentary (29 bal. 2024 @ 06:37):

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally...

Stats
Šios dienos apimtis	265 774
Vidutinė apimtis	533 225
Rinkos kapitalizacija	12.43B
EPS	INR0 ( 2024-02-06 )
Kita pelno data	( INR0 ) 2024-05-23
Last Dividend	INR3.00 ( 2023-09-07 )
Next Dividend	INR0 ( N/A )
P/E	30.85
ATR14	INR0.271 (0.11%)

Tūris Koreliacija

Ilgas: -0.28 (neutral)

Trumpas: 0.06 (neutral)

Signal:(67.593) Neutral

Kopran Limited Koreliacija

10 Labiausiai teigiamai susiję koreliacijos

10 Labiausiai neigiamai susiję koreliacijos

Ar žinojote?

Koreliacija yra statistinis rodiklis, aprašantis ryšį tarp dviejų kintamųjų. Jis svyruoja nuo -1 iki 1, kur -1 reiškia tobulo neigiamo ryšio koreliaciją (padidėjus vienam kintamajam, sumažėja kitas), 1 reiškia tobulo teigiamo ryšio koreliaciją (padidėjus vienam kintamajam, padidėja ir kitas), o 0 reiškia jokios koreliacijos (tarp kintamųjų nėra jokio ryšio).

Koreliacija gali būti naudojama analizuojant bet kurių dviejų kintamųjų ryšį, ne tik akcijų. Jis dažnai naudojamas finansų, ekonomikos, psichologijos ir kitose srityse.

Kopran Limited Koreliacija - Valiuta/Žaliavos

0.27
( neutral )

-0.61
( weak negative )

0.44
( neutral )

-0.12
( neutral )

0.43
( neutral )

Kopran Limited Finansinės ataskaitos

Annual	2022
Pajamos:	INR5.51B
Bruto pelnas:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
Pajamos:	INR5.51B
Bruto pelnas:	INR1.92B (34.92 %)
EPS:	INR5.65

FY	2022
Pajamos:	INR4.74B
Bruto pelnas:	INR1.90B (40.10 %)
EPS:	INR13.77

FY	2021
Pajamos:	INR4.81B
Bruto pelnas:	INR1.67B (34.72 %)
EPS:	INR14.24

Financial Reports:

No articles found.

Kopran Limited Dividends

(Q3/22)	(Q4/22)	(Q1/23)	(Q2/23)	(Q3/23)	(Q4/23)	(Q1/24)	(Q2/24)	(Q3/24)	(Q4/24)
INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR3.00 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)	INR0 (N/A)

Kopran Limited Dividend Information - Dividend Junior

Dividend Sustainability Score: 3.83 - low (27.53%) | Divividend Growth Potential Score: 3.03 - Decrease likely (39.46%)

Very Unsafe

High risk of being cut

Unsafe

Heightened risk of being cut

Borderline

Moderate risk of being cut

Safe

Unlikely to be cut

Very Safe

Very unlikely to be cut

Information

First Dividend	INR1.500	2020-11-05
Last Dividend	INR3.00	2023-09-07
Next Dividend	INR0	N/A
Payout Date	0000-00-00
Next Payout Date	N/A
# dividends	4	--
Total Paid Out	INR9.00	--
Avg. Dividend % Per Year	1.18%	--
Score	2.04	--
Div. Sustainability Score	3.83
Div.Growth Potential Score	3.03
Div. Directional Score	3.43	--

Next Divdend (Est)
(2024-05-20)

INR3.25 Estimate 3.08 %

Dividend Stability

0.25 Very Poor

Dividend Score

2.04

Pay Frequency

Annually

Yearly Payout

Year	Amount	Yield
2020	INR1.500	4.82%
2021	INR1.500	1.08%
2022	INR3.00	0.91%
2023	INR3.00	2.01%
2024	INR0	0.00%

Dividend Commentary

The company's low Dividend Sustainability Score (DSS) highlights potential challenges in upholding its current dividend levels. Unfortunately, its low Dividend Growth Potential Score (DGPS) suggests limited prospects for dividend growth. In conclusion, a more vigilant stance is recommended given the company's tentative dividend landscape.

Top 10 dividend Companies for NSE

Symbol	Title	Last dividend	Frequency	Years Dividend	Yearly Dividend
UBL.NS	Dividend Junior	2023-08-03	Annually	17	0.27%
POLYCAB.NS	Dividend Knight	2023-06-21	Annually	6	0.50%
JSL.NS	Dividend Junior	2023-09-15	Sporadic	22	0.26%
DLF.NS	Dividend Junior	2023-07-28	Annually	18	0.60%
AARON.NS	Dividend Junior	2023-08-28	Sporadic	5	0.36%
SOUTHBANK.NS	Dividend Junior	2023-08-17	Sporadic	25	0.42%
MONARCH.NS	Dividend Junior	2023-09-14	Annually	3	0.20%
HERANBA.NS	Dividend Junior	2023-08-17	Annually	4	0.20%
BHEL.NS	Dividend Junior	2023-08-11	Annually	21	0.26%
RAMCOIND.NS	Dividend Junior	2023-08-02	Annually	23	0.32%

Dividend Sustainability Score (DSS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
netProfitMarginTTM	0.0697	1.500	8.61	10.00	[0 - 0.5]
returnOnAssetsTTM	0	1.200	0	0	[0 - 0.3]
returnOnEquityTTM	0.0917	1.500	-0.0923	-0.139	[0.1 - 1]
payoutRatioTTM	0	-1.000	0	0	[0 - 1]
currentRatioTTM	0	0.800	-5.00	-4.00	[1 - 3]
quickRatioTTM	0	0.800	-4.71	-3.76	[0.8 - 2.5]
cashRatioTTM	0	1.500	-1.111	-1.667	[0.2 - 2]
debtRatioTTM	0	-1.500	0	0	[0 - 0.6]
interestCoverageTTM	7.54	1.000	8.32	8.32	[3 - 30]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
freeCashFlowPerShareTTM	3.38	2.00	8.31	10.00	[0 - 20]
debtEquityRatioTTM	0	-1.500	0	0	[0 - 2.5]
grossProfitMarginTTM	0.356	1.000	7.40	7.40	[0.2 - 0.8]
operatingProfitMarginTTM	0.101	1.000	9.97	9.97	[0.1 - 0.6]
cashFlowToDebtRatioTTM	0	1.000	-1.111	-1.111	[0.2 - 2]
assetTurnoverTTM	0	0.800	-3.33	-2.67	[0.5 - 2]
Total Score				3.83

Dividend Growth Score (DGS)

Ratio	Actual Value	Weight	Normalized Value	Score	Range
peRatioTTM	30.44	1.000	7.03	0	[1 - 100]
returnOnEquityTTM	0.0917	2.50	-0.0594	-0.139	[0.1 - 1.5]
freeCashFlowPerShareTTM	3.38	2.00	8.87	10.00	[0 - 30]
dividendYielPercentageTTM	1.177	1.500	10.00	0	[0 - 0.4]
operatingCashFlowPerShareTTM	8.79	2.00	7.07	10.00	[0 - 30]
payoutRatioTTM	0	1.500	0	0	[0 - 1]
pegRatioTTM	-0.0940	1.500	-3.96	0	[0.5 - 2]
operatingCashFlowSalesRatioTTM	0.0732	1.000	-0.670	0	[0.1 - 0.5]
Total Score				3.03

Kopran Limited

Kopran Limited, an integrated pharmaceutical company, manufactures and sells active pharmaceutical ingredients and finished dosage forms in India and internationally. The company offers its products in various dosage forms, including tablets, capsules, dry powder, suspension, and injectables. It also provides active pharmaceutical ingredients in the categories of macrolide, antibacterial, anticonvulsant, anti-hypertensive, anti-helmentics, anti-histamine, anti-acne, anti-infective, urological, anti-thrombotic, antidiabetic, pain management, gastroenterology, and cardiovascular. The company was incorporated in 1958 and is headquartered in Mumbai, India.